Metabolic and cardiovascular benefits of hydroxychloroquine: exploration in a wider population at high CV risk
Ann Rheum Dis
.
2018 Sep;77(9):e59.
doi: 10.1136/annrheumdis-2017-212499.
Epub 2017 Oct 13.
Authors
Anil Pareek
1
,
Indranil Purkait
2
,
Ravi T Mehta
2
,
Anu Grover
2
Affiliations
1
Medical Affairs and Clinical Research, Ipca Laboratories Ltd., Mumbai, Maharashtra, India.
2
Medical Affairs, Ipca Laboratories Ltd., Mumbai, Maharashtra, India.
PMID:
29030360
DOI:
10.1136/annrheumdis-2017-212499
No abstract available
Keywords:
Cardiovascular Disease; Rheumatoid Arthritis.
Publication types
Letter
Comment
MeSH terms
Arthritis, Rheumatoid*
Humans
Hydroxychloroquine*
Risk Factors
Substances
Hydroxychloroquine